News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Corey Pelletier

Articles by Corey Pelletier

96 Elacestrant Real-World Progression-Free Survival of Adult Patients With ER+/HER2–, Advanced Breast Cancer: A Retrospective Analysis Using Insurance Claims in the United States

ByElyse Swallow,Jessica Maitland,Kirthana Sarathy,Ellen Sears,Yasir Nagarwala,Janelle DePalantino,Eric Kruep,Corey Pelletier,Sebastian Kloss,Tomer Wasserman

April 18th 2025

37 Estimating the Direct and Indirect Resource Burden of Treatment Management With Current Standard of Care or Elacestrant for ER+, HER2–, ESR1-Mutated Advanced or Metastatic Breast Cancer Patients: A Population- Level Provider Model

37 Estimating the Direct and Indirect Resource Burden of Treatment Management With Current Standard of Care or Elacestrant for ER+, HER2–, ESR1-Mutated Advanced or Metastatic Breast Cancer Patients: A Population- Level Provider Model

ByGregory Vidal, MD, PhD,Frank Cinfio,Jack Badaracco,Corey Pelletier,Matthew Gitlin

June 22nd 2024

Latest Updated Articles

Trending on CancerNetwork

ASH 2025: The Top 10 Takeaways for Hematologic Oncology Care

FDA Approves T-DXd Plus Pertuzumab in Metastatic HER2+ Breast Cancer

FDA Grants National Priority Voucher to Teclistamab/Daratumumab in RRMM

ASH 2025: Key Discussions in Multiple Myeloma, Lymphoma, and Leukemia

MATTERHORN Results Yield Promise in Resectable Gastric/GEJ Cancer

© 2025 MJH Life Sciences^®

All rights reserved.